Clin2
NCT07528053Likely a fitNot yet recruiting

Testing an investigational medicine in healthy volunteers

HV

This trial tests a new medication (called BW-20805-2-1001) in healthy volunteers to see if it is safe and how the body handles it. It may help in developing future treatments for certain diseases, though it's not yet known if it will benefit you directly.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
24 people
Ages
18 years to 60 years
Study type
Interventional

Who can take part

  • You must be a healthy adult, aged 18 to 60 years.
  • Your body mass index (BMI) should be between 18 and 32, and your weight should be at least 50 kg (about 110 lbs).
  • You cannot be pregnant or planning to become pregnant, and if you're a male with a partner who could become pregnant, you must use effective birth control for a long period (about 48 weeks) after the study.
  • You should not have any serious medical conditions, active infections (like hepatitis B), or a history of cancer.
  • Your blood pressure must be within normal range (not consistently above 140/90 mmHg).
  • You must not be taking any prescription or over-the-counter medications (except birth control), including any investigational drugs within the last 30 days.
  • You must not have had siRNA treatment (a type of gene-silencing therapy) in the past 12 months.
  • You should not smoke more than 10 cigarettes (or equivalent) per day, and you must be willing to avoid smoking for 48 hours before staying at the clinic.
  • You cannot have a history of alcohol or drug abuse in the past 12 months, and you must pass drug and alcohol tests.
  • You must not have donated a large amount of blood (over 200 mL) in the past 30 days.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07584876Recruiting· Phase 1
Safety study of a new blood clotting medicine in healthy adults

This is an early-stage safety study testing a new experimental medicine that affects blood clotting in people with no serious health conditions. Researchers want to make sure the medicine is safe and well-tolerated before testing it in patients who need it.

Perth, Western Australia
NCT06859853Recruiting· Phase 1
MWN109 injection safety study in healthy volunteers

This trial tests an investigational injection called MWN109 to see if it is safe and how the body processes it. It is for healthy adults only, and the results will help decide if the drug should be tested in people with medical conditions.

Melbourne, Victoria
NCT07029932Recruiting· Phase 1
Testing the safety of multiple doses of BWC0977 in healthy people

This study tests an experimental antibiotic called BWC0977 to see if it is safe and well-tolerated when given as single and multiple doses. It is for healthy volunteers to understand how the drug behaves in the body before moving to patient trials.

Melbourne, Victoria
NCT06917482Recruiting· Phase 1
Testing a new drug called BW-40202 in healthy people

This study tests a new medicine called BW-40202 for the first time in people. It is for healthy volunteers to see if the drug is safe and how it works in the body. You must be in good general health to take part.

Brisbane, Queensland
NCT07448194Recruiting· Phase 1
Safety study of HW241045 in healthy adults

This trial tests the safety of a new drug called HW241045 in healthy volunteers. It helps doctors understand how the drug affects the body and if it causes any side effects.

Beijing
NCT07493031Not yet recruiting· Phase 1
Safety study of HW252001 in healthy adults

This study tests a new investigational drug, HW252001, in healthy volunteers to see how safe it is and how the body handles it. If you qualify, you would help researchers find the right dose for future studies.

Wuhan, Hubei

Hear when a new HV trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.